Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze EDIT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate EDIT investment potential.

What is EDIT stock price today?

Get real-time EDIT stock price, historical data, and price charts on Financhill. Track EDIT performance with our advanced analysis tools.

Is EDIT a good investment?

Evaluate EDIT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy EDIT stock?

To buy EDIT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of EDIT?

View detailed market capitalization data and company valuation metrics for EDIT on our comprehensive analysis page.

What is the P/E ratio of EDIT?

Use our fundamental analysis tools to view EDIT P/E ratio and compare valuation metrics with industry peers.

What are EDIT earnings?

View EDIT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Editas Medicine, Inc. 10K Form

Sell

EDIT
Editas Medicine, Inc.

Last Price:

$2.44

Seasonality Move:

-1.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EDIT News And Ratings

See the #1 stock for the next 7 days that we like better than EDIT

EDIT Financial Statistics

Sales & Book Value

Annual Sales:	$32.3M
Cash Flow:	$-31.3M
Price / Cash Flow:	0
Annual Sales:	$0.14
Price / Book:	17.63

Profitability

EPS (TTM):	-2.37750
Net Income (TTM):	$-199.8M
Gross Margin:	$26.5M
Return on Equity:	-246.73%
Return on Assets:	-74.28%

Editas Medicine, Inc. Earnings Forecast

Key Editas Medicine, Inc. Financial Ratios

The Gross Profit Margin over the past 4 years for EDIT is 82.02%.
The Selling, General & Administrative Expenses for EDIT have been equal to 222.77% of Gross Profit Margin.
The Research & Development expenses have been 598.62% of Revenue.
The Net Earning history of EDIT is -733.72% of Total Revenues.
Per Share Earnings over the last 11 years have been positive in 4 years.

Editas Medicine, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	EDIT
CUSIP:	28106W
Website:	editasmedicine.com

Debt

Debt-to-Equity Ratio:	5.85
Current Ratio:	2.86
Quick Ratio:	2.81

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

EDIT Technical Analysis vs Fundamental Analysis